Panic disorder: The ultimate anxiety

Journal of Women's Health

Volumn 7, Issue 8, 1998, Pages 983-989

  Sansone, Randy A ^a,c   Sansone, Lori A ^b   Righter, Elisabeth L ^a  

^a WRIGHT STATE UNIVERSITY   (United States)

^b KETTERING MEDICAL CENTER   (United States)

^c Sycamore Primary Care Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SEROTONIN UPTAKE INHIBITOR;

AGORAPHOBIA; BEHAVIOR THERAPY; COGNITIVE THERAPY; FEMALE; HUMAN; ONSET AGE; PANIC; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; REVIEW; SEX DIFFERENCE;

EID: 0031754169     PISSN: 10597115     EISSN: None     Source Type: Journal    
DOI: 10.1089/jwh.1998.7.983     Document Type: Review

References (69)

1. Klerman GL, Weissman MM, Ouellette R, Johnson J, Greenwald S. Panic attacks in the community. Social morbidity and health care utilization. JAMA 1991;265:742.
2. Kessler RC, McGonagle KA, Zhao S, et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry 1994;51:8.
3. Eaton WW, Kessler RC, Wittchen HU, et al. Panic and panic disorder in the United States. Am J Psychiatry 1994;151:413.
4. Hassan R, Pollard CA. Late-life-onset panic disorder: Clinical and demographic characteristics of a patient sample. J Geriatr Psychiatry Neurol 1994;7:84.
5. Katerndahl DA, Realini JP. Where do panic attack sufferers seek care? J Fam Pract 1995;40:237.
6. Salvador-Carulla L, Segui J, Fernandez-Cano P, Canet J. Costs and offset effect in panic disorders. Br J Psychiatry 1995;27(Suppl):23.
7. Weissman MM. Family genetic studies of panic disorder. J Psychiatric Res 1993;27:69.
8. Kendler KS, Walters EE, Truett KR, et al. A twin-family study of self-report symptoms of panic-phobia and somatization. Behav Genet 1995;25:499.
9. Goldstein RB, Weissman MM, Adams PB, et al. Psychiatric disorders in relatives of probands with panic disorder and/or major depression. Arch Gen Psychiatry 1994;51:383.
10. Battaglia M, Bertella S, Politi E, et al. Age at onset of panic disorder: Influence of familial liability to the disease and of childhood separation anxiety disorder. Am J Psychiatry 1995;152:1362.
11. Wickramaratne PJ, Weissman MM, Horwath E, Adams P. The familial aggregation of panic disorder by source of proband ascertainment. Psychiatr Genet 1994;4:125.
12. Kendler KS, Neale MC, Kessler RC, Heath AC, Eaves LJ. Panic disorder in women: A population-based twin study. Psychol Med 1993;23:397.
13. Paniccia GS, Rapaport MH. Serotonin receptors, social phobia and panic disorder. Int Rev Psychiatry 1995;7:131.
14. Sheehan DV, Raj BA, Trehan RR, Knapp EL. Serotonin in panic disorder and social phobia. Int Clin Psychopharmacol 1993;8:63.
15. Lipsitz JD, Martin LY, Mannuzza S, et al. Childhood separation anxiety disorder in patients with adult anxiety disorders. Am J Psychiatry 1994;151:927.
16. King NJ, Ollendick TH, Mattis SG. Panic in children and adolescents: Normative and clinical studies. Aust Psychol 1994;29:89.
17. Silove D, Harris M, Morgan A, et al. Is early separation anxiety a specific precursor of panic disorderagoraphobia? A community study. Psychol Med 1995; 25:405.
18. Shear MK. Factors in the etiology and pathogenesis of panic disorder: Revisiting the attachment-separation paradigm. Am J Psychiatry 1996;153:125.
19. Boulenger J-P, Jerabek I, Jolicoeur FB, Lavallee YJ, Leduc R, Cadieux A. Elevated plasma levels of neuropeptide Y in patients with panic disorder. Am J Psychiatry 1996;153:114.
20. Abelson JL, Curtis GC. Hypothalamic-pituitaryadrenal axis activity in panic disorder. 24-hour secretion of corticotropin and cortisol. Arch Gen Psychiatry 1996;53:323.
21. Birchall HM. Are gonadotrophic homonal factors perceived to be important by women with panic attacks? Anxiety 1994;1:102.
22. Wagner KD, Berenson AB. Norplant-associated major depression and panic disorder. J Clin Psychiatry 1994;55:478.
23. Deci PA, Lydiard RB, Santos AB, Arana GW. Oral contraceptives and panic disorder. J Clin Psychiatry 1992;53:163.
24. Bouwer C, Stein DJ. Association of panic disorder with a history of traumatic suffocation. Am J Psychiatry 1997;154:1566.
25. Warner V, Mufson L, Weissman MM. Offspring at high and low risk for depression and anxiety: Mechanisms of psychiatric disorder. J Am Acad Child Adolesc Psychiatry 1995;34:786.
26. David D, Giron A, Mellman TA. Panic-phobic patients and developmental trauma. J Clin Psychiatry 1995;56:113.
27. Stein MB, Walker JR, Anderson G, et al. Childhood physical and sexual abuse in patients with anxiety disorders and in a community sample. Am J Psychiatry 1996;153:275.
28. Moisan D, Engels ML. Childhood trauma and personality disorder in 43 women with panic disorder. Psychol Rep 1995;76:1133.
29. Charney DS, Heninger GR, Jatlow PI. Increased anxiogenic effects of caffeine in panic disorders. Arch Gen Psychiatry 1985;42:233.
30. Kaspi SP, Otto MW, Pollack MH, et al. Premenstrual exacerbation of symptoms in women with panic disorder. J Anxiety Disord 1994;8:131.
31. Cohen LS, Sichel DA, Dimmock JA, Rosenbaum JF. Impact of pregnancy on panic disorder: A case series. J Clin Psychiatry 1994;55:284.
32. Cohen LS, Sichel DA, Dimmock JA, Rosenbaum JF. Postpartum course in women with preexisting panic disorder. J Clin Psychiatry 1994;55:289.
33. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th ed. Washington, DC: American Psychiatric Association, 1994.
34. Missri JC, Alexander S. Hyperventilation syndrome. A brief review. JAMA 1978;240:2093.
35. Lydiard RB, Greenwald S, Weissman MM, Johnson J, Drossman DA, Ballenger JC. Panic disorder and gastrointestinal symptoms: Findings from the NIMH Epidemiologic Catchment Area project. Am J Psychiatry 1994;151:64.
36. Ball S, Shekhar A. Basilar artery response to hyperventilation in panic disorder. Am J Psychiatry 1997; 154:1603.
37. Stein MB, Asmundson GJG, Ireland D, Walker JR. Panic disorder in patients attending a clinic for vestibular disorders. Am J Psychiatry 1994;151:1697.
38. Mavissakalian MR, Ryan MT. Recent advances in pharmacologic and psychosocial treatments of panic disorder. Essent Psychopharmacol 1996;1:108.
39. Shear MK, Cooper AM, Klerman GL, Busch FN, Shapiro T. A psychodynamic model of panic disorder. Am J Psychiatry 1993;150:859.
40. Marshall JR. Comorbidity and its effects on panic disorder. Bull Menninger Clin 1996;60:A39.
41. Pollack MH, Otto MW. Long-term pharmacologic treatment of panic disorder. Psychiatr Ann 1994;24: 291.
42. Pecknold JC, Luthe L, Iny L, Ramdoyal D. Fluoxetine in panic disorder: Pharmacologic and tritiated platelet imipramine and paroxetine binding study. J Psychiatry Neurosci 1995;20:193.
43. Boyer W. Serotonin uptake inhibitors are superior to imipramine and alprazolam in alleviating panic attacks: A meta-analysis. Int Clin Psychopharmacol 1995;10:45.
44. Dewulf L, Hendrickx B, Lesaffre E. Epidemiological data of patients treated with fluvoxamine: Results from a 12 week non-comparative multicentre study. Int Clin Psychopharmacol 1995;9:67.
45. Den Boer JA, Westenberg HGM. Serotonergic compounds in panic disorder, obsessive-compulsive disorder and anxious depression: A concise review. Hum Psychopharmacol 1995;10:S173.
46. Sheehan DV, Ballenger JC, Jacobson G. Treatment of endogenous anxiety with phobic, hysterical, and hypochondriacal symptoms. Arch Gen Psychiatry 1980;37:51.
47. Geracioti TD. Venlafaxine treatment of panic disorder: A case series. J Clin Psychiatry 1995;56:408.
48. Woodman CL, Noyes R. Panic disorder: Treatment with valproate. J Clin Psychiatry 1994;55:134.
49. Cassano GB, Toni C, Petracca A, Deltito J, et al. Adverse effects associated with the short-term treatment of panic disorder with imipramine, alprazolam or placebo. Eur Neuropsychopharmacol 1994;4:47.
50. Curran HV, Bond A, O'Sullivan G, Bruce M, et al. Memory functions, alprazolam and exposure therapy: A controlled longitudinal study of agoraphobia with panic disorder. Psychol Med 1994;24:969.
51. O'Sullivan GH, Noshirvani H, Basoglu M, et al. Safety and side-effects of alprazolam: Controlled study in agoraphobia with panic disorder. Br J Psychiatry 1994;165:79.
52. Salzman C. Benzodiazepine treatment of panic disorder and agoraphobic symptoms: Use, dependence, toxicity, abuse. J Psychiatr Res 1993;27:97.
53. Pecknold JC. Discontinuation reactions to alprazolam in panic disorder. J Psychiatr Res 1993;27:155.
54. Gould RA, Otto MW, Pollack MH. A meta-analysis of treatment outcome for panic disorder. Clin Psychol Rev 1995;15:819.
55. Rangaswami K, Kaliappan KV. Cognitive-behavioural management of panic disorder: An update. Indian J Clin Psychol 1995;22:45.
56. Gelder MG, Clark DM, Salkovskis P. Cognitive treatment for panic disorder. J Psychiatr Res 1993;27:171.
57. Ballenger JC. Panic disorder: Efficacy of current treatments. Psychopharmacol Bull 1993;29:477.
58. Busch F, Milrod B, Cooper A, Shapiro T. Psychodynamic approaches to panic disorder. J Psychother Pract Res 1995;5:73.
59. Milrod B, Rusch F, Cooper A, Shapiro T. Manual of panic-focused psychodynamic psychotherapy. Washington, DC: American Psychiatric Press, 1997.
60. Faravelli C, Paterniti S, Scarpato A. 5-year prospective, naturalistic follow-up study of panic disorder. Compr Psychiatry 1995;36:271.
61. Brown TA, Barlow DH. Long-term outcome in cognitive-behavioral treatment of panic disorder: Clinical predictors and alternative strategies for assessment. J Consult Clin Psychol 1995;63:754.
62. Rosenberg NK, Rosenberg R. Three years follow-up of panic disorder patients: A naturalistic study. Scand J Psychol 1994;35:254.
63. Wittchen HU, Essau CA. Epidemiology of panic disorder: Progress and unresolved issues. J Psychiatr Res 1993;27:47.
64. Hollifield M, Katon W, Skipper B, et al. Panic disorder and quality of life: Variables predictive of functional impairment. Am J Psychiatry 1997;154:766.
65. Noyes R Jr, Reich J, Christiansen J, Suelzer M, Pfohl B, Coryell WA. Outcome of panic disorder. Relationship to diagnostic subtypes and comorbidity. Arch Gen Psychiatry 1990;47:809.
66. Brown TA, Antony MM, Barlow DH. Diagnostic Comorbidity in panic disorder: Effect on treatment outcome and course of comorbid diagnoses following treatment. J Consult Clin Psychol 1995;63:408.
67. Scheibe G, Albus M. Prospective follow-up study lasting 2 years in patients with panic disorder with and without depressive disorders. Eur Arch Psychiatry Clin Neurosci 1994;244:39.
68. Fava GA, Zielezny M, Savron G, Grandi S. Long-term effects of behavioural treatment for panic disorder with agoraphobia. Br J Psychiatry 1995;166:87.
69. Albus M, Scheibe G, Scherer J. Panic disorder with or without concomitant depression 5 years after treatment: A prospective follow-up. J Affect Disord 1995;34:109.